• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Takeda and Shattuck Labs partner to develop immunotherapies for cancer treatments pharmaceutical-technology
    August 15, 2017
    Takeda Pharmaceutical has entered a research collaboration with Shattuck Labs to study and develop checkpoint fusion proteins that have the potential to be used as highly differentiated, advanced immunotherapies for cancer.
  • Takeda, Shattuck Labs Announce Research Collaboration americanpharmaceuticalreview
    August 11, 2017
    Takeda Pharmaceutical Company and Shattuck Labs announced they have entered into a research collaboration to explore and develop checkpoint fusion proteins，Takeda will hold options for exclusive global development and commercialization rights for up to fo

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service